TherapeuticsMD (TXMD) Shares Outstanding (Weighted Average) (2010 - 2026)

TherapeuticsMD has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $11574.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.19% year-over-year to $11574.0; the trailing twelve-month figure through Mar 2026 stood at $11574.0 (changed 0.19% YoY), and the FY2025 full-year result was $11.6 million, changed 0.32% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $11574.0, down from $11.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $11.6 million in Q3 2025, with the low at $10441.0 in Q4 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $8.7 million across 5 years, with a median of $10.2 million in 2023.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) surged 110349.19% — and 2025, when it sank 99.9%.
• TherapeuticsMD's Shares Outstanding (Weighted Average) stood at $9.0 million in 2022, then slumped by 99.88% to $10441.0 in 2023, then surged by 110349.19% to $11.5 million in 2024, then increased by 0.32% to $11.6 million in 2025, then sank by 99.9% to $11574.0 in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $11574.0 (Q1 2026), $11.6 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.